These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 21555347

  • 1. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
    Bernstine H, Braun M, Yefremov N, Lamash Y, Carmi R, Stern D, Steinmetz A, Sosna J, Groshar D.
    Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
    [Abstract] [Full Text] [Related]

  • 2. Combined early dynamic 18F-FDG PET/CT and conventional whole-body 18F-FDG PET/CT in hepatocellular carcinoma.
    Zhang Y, Dong Y, Yu W, Chen S, Yu H, Li B, Shi H.
    Abdom Radiol (NY); 2023 Oct; 48(10):3127-3134. PubMed ID: 37439840
    [Abstract] [Full Text] [Related]

  • 3. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM, Chang T, Graham MM, Marquardt MD, Button A, Smith BJ, Menda Y, Sun W, Pagedar NA, Buatti JM.
    Int J Radiat Oncol Biol Phys; 2015 Mar 01; 91(3):472-9. PubMed ID: 25680593
    [Abstract] [Full Text] [Related]

  • 4. Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions.
    Schierz JH, Opfermann T, Steenbeck J, Lopatta E, Settmacher U, Stallmach A, Marlowe RJ, Freesmeyer M.
    J Nucl Med; 2013 Jun 01; 54(6):848-54. PubMed ID: 23528383
    [Abstract] [Full Text] [Related]

  • 5. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
    Song HJ, Cheng JY, Hu SL, Zhang GY, Fu Y, Zhang YJ.
    Clin Radiol; 2015 Feb 01; 70(2):128-37. PubMed ID: 25459673
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY, Kao CH, Huang WS, Chen CM, Chang LP, Lee MS, Chao HL, Chiu CH, Lo CH, Jen YM.
    J Nucl Med; 2013 Oct 01; 54(10):1710-6. PubMed ID: 23970365
    [Abstract] [Full Text] [Related]

  • 7. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Lee JW, Yun M, Cho A, Han KH, Kim DY, Lee SM, Lee JD.
    Ann Nucl Med; 2015 Jun 01; 29(5):400-8. PubMed ID: 25652647
    [Abstract] [Full Text] [Related]

  • 8. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.
    Talbot JN, Gutman F, Fartoux L, Grange JD, Ganne N, Kerrou K, Grahek D, Montravers F, Poupon R, Rosmorduc O.
    Eur J Nucl Med Mol Imaging; 2006 Nov 01; 33(11):1285-9. PubMed ID: 16802155
    [Abstract] [Full Text] [Related]

  • 9. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
    Song JY, Lee YN, Kim YS, Kim SG, Jin SJ, Park JM, Choi GS, Chung JC, Lee MH, Cho YH, Choi MH, Kim DC, Choi HJ, Moon JH, Lee SH, Jeong SW, Jang JY, Kim HS, Kim BS.
    Nucl Med Commun; 2015 Apr 01; 36(4):319-27. PubMed ID: 25564069
    [Abstract] [Full Text] [Related]

  • 10. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, Zeuzem S.
    Am J Gastroenterol; 1999 Nov 01; 94(11):3314-9. PubMed ID: 10566736
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
    Kim JW, Seong J, Yun M, Lee IJ, Yoon HI, Cho HJ, Han KH.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1172-8. PubMed ID: 21570203
    [Abstract] [Full Text] [Related]

  • 14. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
    Wolfort RM, Papillion PW, Turnage RH, Lillien DL, Ramaswamy MR, Zibari GB.
    Int Surg; 2010 Mar 01; 95(1):67-75. PubMed ID: 20480845
    [Abstract] [Full Text] [Related]

  • 15. 18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
    Cho E, Jun CH, Kim BS, Son DJ, Choi WS, Choi SK.
    Turk J Gastroenterol; 2015 Jul 01; 26(4):344-50. PubMed ID: 26039005
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
    Song MJ, Bae SH, Yoo IeR, Park CH, Jang JW, Chun HJ, Choi BG, Lee HG, Choi JY, Yoon SK.
    World J Gastroenterol; 2012 Jul 07; 18(25):3215-22. PubMed ID: 22783045
    [Abstract] [Full Text] [Related]

  • 17. [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
    Kong YH, Han CJ, Lee SD, Sohn WS, Kim MJ, Ki SS, Kim J, Jeong SH, Kim YC, Lee JO, Cheon GJ, Choi CW, Lim SM.
    Korean J Hepatol; 2004 Dec 07; 10(4):279-87. PubMed ID: 15613803
    [Abstract] [Full Text] [Related]

  • 18. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M, Erba P, Volterrani D, Guidoccio F, Lazzeri E, Caramella D, Mariani G.
    AJR Am J Roentgenol; 2011 Jul 07; 197(1):209-16. PubMed ID: 21701032
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.
    Hectors SJ, Wagner M, Besa C, Huang W, Taouli B.
    Contrast Media Mol Imaging; 2018 Jul 07; 2018():5638283. PubMed ID: 30402045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.